← Oncology Approval Tracker

FDA DECISION ·

Xpovio + bortezomib + dexamethasone

selinexor + bortezomib + dexamethasone · Karyopharm Therapeutics

FDA approvalNew or expanded indicationMultiple myeloma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with multiple myeloma after at least one prior therapy, in combination with bortezomib and dexamethasone.

LAMPGEN ANALYSIS

Why it matters

Moved selinexor into an earlier myeloma treatment setting as part of a three-drug regimen.

What research teams should watch

Match the weekly schedule and monitor gastrointestinal symptoms, blood counts and sodium.

PRIMARY RECORDS

Sources